Literature DB >> 33413589

Exosomes secreted by chemoresistant ovarian cancer cells promote angiogenesis.

Zhang Li1,2, Wang Yan-Qing1, Yang Xiao1, Liu Shi-Yi1, Yuan Meng-Qin1, Xian Shu1, Yang Dong-Yong1, Zheng Ya-Jing1, Cheng Yan-Xiang3.   

Abstract

BACKGROUND: Ovarian cancer (OC) has the highest mortality rate in gynecologic tumors. Despite decades of continuous efforts, the survival rate of patients has not improved significantly, mostly due to drug resistance. Exosomes are hot topics in recent years. Cells can affect the biological behaviors of other cells by transferring exosomes. So far, numerous researchers have found that tumor cells can secrete exosomes which play a important role in the development of tumors. Solid tumors can promote angiogenesis. When drug resistance occurs, it seems that more blood vessels form. We suppose that exosomes derived from chemoresistant OC cells can also promote angiogenesis.
RESULTS: We investigate whether exosomes secreted by chemoresistant SKOV3-DDP cells (SKOV3-DDP-exo) and sensitive SKOV3 cells (SKOV3-exo) influence angiogenesis. After exosomes were extracted, exosomes were co-cultured with HUVECs. We found that SKOV3-DDP-exo and SKOV3-exo are absorbed by endothelial cells and promote the proliferation, migration, invasion and tube formation of endothelial cells. Moreover, SKOV3-DDP-exo is more powerful in angiogenesis, suggesting that parts of the components of SKOV3-DDP-exo are significantly radical. We also found that miR-130a was highly expressed in drug-resistant OC cells. Also, we found that miR-130a in SKOV3-DDP-exo is higher than SKOV3-exo. Therefore, we suggest that miR-130a in exosomes is the main cause of chemoresistant OC cells promoting angiogenesis.

Entities:  

Keywords:  Angiogenesis; Drug resistance; Exosomes; Ovarian cancer; miR-130a

Year:  2021        PMID: 33413589      PMCID: PMC7792113          DOI: 10.1186/s13048-020-00758-w

Source DB:  PubMed          Journal:  J Ovarian Res        ISSN: 1757-2215            Impact factor:   4.234


  29 in total

1.  Abnormal lysosomal trafficking and enhanced exosomal export of cisplatin in drug-resistant human ovarian carcinoma cells.

Authors:  Roohangiz Safaei; Barrett J Larson; Timothy C Cheng; Michael A Gibson; Shinji Otani; Wiltrud Naerdemann; Stephen B Howell
Journal:  Mol Cancer Ther       Date:  2005-10       Impact factor: 6.261

2.  Isolation and characterization of exosomes from cell culture supernatants and biological fluids.

Authors:  Clotilde Théry; Sebastian Amigorena; Graça Raposo; Aled Clayton
Journal:  Curr Protoc Cell Biol       Date:  2006-04

Review 3.  Tumor angiogenesis: therapeutic implications.

Authors:  J Folkman
Journal:  N Engl J Med       Date:  1971-11-18       Impact factor: 91.245

4.  ICAM-1 on exosomes from mature dendritic cells is critical for efficient naive T-cell priming.

Authors:  Elodie Segura; Carole Nicco; Bérangère Lombard; Philippe Véron; Graça Raposo; Frédéric Batteux; Sebastian Amigorena; Clotilde Théry
Journal:  Blood       Date:  2005-03-24       Impact factor: 22.113

5.  Altered microRNA expression in cisplatin-resistant ovarian cancer cells and upregulation of miR-130a associated with MDR1/P-glycoprotein-mediated drug resistance.

Authors:  Lingyun Yang; Ningwei Li; Hongjing Wang; Xibiao Jia; Xue Wang; Juan Luo
Journal:  Oncol Rep       Date:  2012-05-18       Impact factor: 3.906

6.  Salivary gland epithelial cell exosomes: A source of autoantigenic ribonucleoproteins.

Authors:  Efstathia K Kapsogeorgou; Rasmi F Abu-Helu; Haralampos M Moutsopoulos; Menelaos N Manoussakis
Journal:  Arthritis Rheum       Date:  2005-05

7.  Regulation of exosome release from mammary epithelial and breast cancer cells - a new regulatory pathway.

Authors:  Andrew Riches; Elaine Campbell; Eva Borger; Simon Powis
Journal:  Eur J Cancer       Date:  2014-01-22       Impact factor: 9.162

Review 8.  Targeting the tumor microenvironment: from understanding pathways to effective clinical trials.

Authors:  Hua Fang; Yves A Declerck
Journal:  Cancer Res       Date:  2013-08-02       Impact factor: 12.701

Review 9.  Targeting the tumor microenvironment for cancer therapy.

Authors:  Nor Eddine Sounni; Agnès Noel
Journal:  Clin Chem       Date:  2012-11-28       Impact factor: 8.327

10.  Exosomal miR-9 inhibits angiogenesis by targeting MDK and regulating PDK/AKT pathway in nasopharyngeal carcinoma.

Authors:  Juan Lu; Qi-Hui Liu; Fan Wang; Jia-Jie Tan; Yue-Qin Deng; Xiao-Hong Peng; Xiong Liu; Bao Zhang; Xia Xu; Xiang-Ping Li
Journal:  J Exp Clin Cancer Res       Date:  2018-07-13
View more
  7 in total

Review 1.  Emerging role of exosomes in cancer progression and tumor microenvironment remodeling.

Authors:  Mahshid Deldar Abad Paskeh; Maliheh Entezari; Sepideh Mirzaei; Amirhossein Zabolian; Hossein Saleki; Mohamad Javad Naghdi; Sina Sabet; Mohammad Amin Khoshbakht; Mehrdad Hashemi; Kiavash Hushmandi; Gautam Sethi; Ali Zarrabi; Alan Prem Kumar; Shing Cheng Tan; Marios Papadakis; Athanasios Alexiou; Md Asiful Islam; Ebrahim Mostafavi; Milad Ashrafizadeh
Journal:  J Hematol Oncol       Date:  2022-06-28       Impact factor: 23.168

2.  An Aptamer-Based Antagonist against the Receptor for Advanced Glycation End-Products (RAGE) Blocks Development of Colorectal Cancer.

Authors:  Jihui Zheng; Wenjing Zhu; Fang He; Zhu Li; Na Cai; Hong-Hui Wang
Journal:  Mediators Inflamm       Date:  2021-05-05       Impact factor: 4.711

Review 3.  Nucleic acids and proteins carried by exosomes of different origins as potential biomarkers for gynecologic cancers.

Authors:  Miaomiao Ye; Jing Wang; Shuya Pan; Lihong Zheng; Zhi-Wei Wang; Xueqiong Zhu
Journal:  Mol Ther Oncolytics       Date:  2021-12-09       Impact factor: 7.200

Review 4.  Advances in Exosomes as Diagnostic and Therapeutic Biomarkers for Gynaecological Malignancies.

Authors:  Mengdan Miao; Yifei Miao; Yanping Zhu; Junnan Wang; Huaijun Zhou
Journal:  Cancers (Basel)       Date:  2022-09-28       Impact factor: 6.575

5.  Exosomes in the f ield of reproduction: A scientometric study and visualization analysis.

Authors:  Yifeng Shen; Yaodong You; Kun Zhu; Chunyan Fang; Degui Chang; Xujun Yu
Journal:  Front Pharmacol       Date:  2022-09-23       Impact factor: 5.988

Review 6.  Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion.

Authors:  Wanjia Tian; Ningjing Lei; Junying Zhou; Mengyu Chen; Ruixia Guo; Bo Qin; Yong Li; Lei Chang
Journal:  Cell Death Dis       Date:  2022-01-18       Impact factor: 8.469

Review 7.  Comparing the Secretomes of Chemorefractory and Chemoresistant Ovarian Cancer Cell Populations.

Authors:  Amy H Lee; Carolina Mejia Peña; Michelle R Dawson
Journal:  Cancers (Basel)       Date:  2022-03-10       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.